• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKM:CN

16.4200 CAD 0.2200 1.36%

As of 13:00:00 ET on 12/24/2014.

Company Profile for Tekmira Pharmaceuticals Corp (TKM)

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Contact Information

Tekmira Pharmaceuticals Corp

100-8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
Canada
Phone: 1-604-419-3200
Fax: 1-604-419-3201

Key Executives for Tekmira Pharmaceuticals Corp (TKM)

Mark J MurrayPresident/CEOBruce CousinsExec VP:Finance/CFO
Ian MaclachlanExec VP/Chief Technical OfficerMichael J AbramsExec VP/Chief Discovery Officer
Mark KowalskiSenior VP/Chief Medical OfficerPeter LutwycheSenior VP:Pharmaceutical Dev
Julie P RezlerDirector:Investor RelationsJodi RegtsDir:Investor Relations
R Hector Mackay-DunnSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil